The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA.
The N-formyl peptide receptors (FPRs) have been identified within neuronal tissues and may serve as yet undetermined functions within the nervous system. The FPRs have been implicated in the progression and invasiveness of neuroblastoma and other cancers. In this study the effects of the synthetic F...
Main Authors: | Peter J G Cussell, Michael S Howe, Thomas A Illingworth, Margarita Gomez Escalada, Nathaniel G N Milton, Andrew W J Paterson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0217815 |
Similar Items
-
The Pyrazolone Originally Reported to Be a Formyl Peptide Receptor (FPR) 2/ALX–Selective Agonist Is Instead an FPR1 and FPR2/ALX Dual Agonist
by: Yoshitaka Sogawa, et al.
Published: (2009-01-01) -
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis
by: Letizia Crocetti, et al.
Published: (2021-10-01) -
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis
by: Julie Le Naour, et al.
Published: (2023-12-01) -
Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophages.
by: Claudio Gemperle, et al.
Published: (2012-01-01) -
Role of formyl peptide receptor 2 (FPR2) in the normal brain and in neurological conditions
by: Wei-Yi Ong, et al.
Published: (2019-01-01)